The lack of scientific attention devoted to the placebo effect as a phenomenon in its own right probably reflects the paucity of theoretical positions within which to organize the existing data and design new research. This research proposal addresses the clinical significance of behavior-immune system interactions, and will advance the analysis of the placebo effect from a descriptive to an experimental analysis as a reflection of learning processes. Conditioning is an inherent component of most pharmacotherapeutic regimens. The proposed research will capitalize on conditioned immunosuppressive responses to reduce the cumulative amount of cyclosporin medication used in the treatment of psoriasis. Patients would continue to be treated with cyclosporin, but experimental patients would be shifted from their current schedule of continuous reinforcement (active drug whenever medication is taken) to a partial schedule of reinforcement (active drug a percentage of the time and placebo at other times). To equate amounts of medication, other patients would be treated with a reduced dose of cyclosporin in a standard treatment regimen. It is hypothesized that, holding the cumulative dose constant, a partial schedule of reinforcement will enable patients to maintain a lower cumulative amount of cyclosporin than patients treated under a continuous schedule of active drug. Psoriasis is an especially appropriate model to evaluate the therapeutic effect of partial schedules of pharmacologic reinforcement, which could decrease the amount of total drug required and the deleterious """"""""side"""""""" effects of long-term cyclosporin treatment. It may be possible to increase the benefit:/risk ratio of drug therapy and reduce the costs of medication. The proposed research is not an attempt to offer a behavioral alternative to drug treatment;it is an attempt to add a behavioral dimension to the design of drug treatment protocols allowing for the reduction in the dosage of immunosuppressive medication. This is the first attempt to adopt conditioning principles and use schedules of reinforcement to design regimens of systemic drug therapy. If proven effective, this new approach to pharmacotherapy and placebo effects is likely to stimulate new interdisciplinary research in neuropharmacology and behavioral pharmacology for the treatment of inflammatory and other chronic disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR050100-05
Application #
7668466
Study Section
Behavioral Medicine, Interventions and Outcomes Study Section (BMIO)
Program Officer
Cibotti, Ricardo
Project Start
2005-09-09
Project End
2013-08-31
Budget Start
2009-09-01
Budget End
2013-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$572,094
Indirect Cost
Name
University of Rochester
Department
Dermatology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Vegas, Oscar; Poligone, Brian; Blackcloud, Paul et al. (2018) Chronic social stress Ameliorates psoriasiform dermatitis through upregulation of the Hypothalamic-Pituitary-Adrenal axis. Brain Behav Immun 68:238-247
Vegas, Oscar; VanBuskirk, JoAnne; Richardson, Steven et al. (2012) Effects of psychological stress and housing conditions on the delay of wound healing. Psicothema 24:581-6
Smith, Nana; Fuhrmann, Tracy; Tausk, Francisco (2009) Psychoneuro-oncology: its time has arrived. Arch Dermatol 145:1439-42